CRNX - Crinetics Pharmaceuticals In
This page shows which of the focused investors we track hold CRNX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2024 it was held by 1 manager with an aggregate reported value of $13.84M, which is 0.00% of the combined portfolio.
As of Q2 2024, 1 tracked institutional manager held CRNX (Crinetics Pharmaceuticals In) with an aggregate reported value of $13.84M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CRNX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2024
- Ticker
- CRNX
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.49% | - | 309,000 | $13.84M |
Loading holder history for CRNX…